Clinical Trial Update: Combination Therapy Using Cellcept and Rebif in RRMS [EARLY_Phase 1]

View source ↗

Summary

The document reports an early-phase 1 clinical trial examining the combination of Cellcept (mycophenolate mofetil) and Rebif (interferon beta-1a) in relapsing-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Rebif (interferon beta-1a)

Snippet

Sponsor: Aaron Boster | Conditions: Multiple Sclerosis | EARLY_Phase 1 | Status: COMPLETED